STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY

STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY

Objective: to investigate the impact of VDR and MCP-1 gene polymorphisms on the efficiency of 12-month therapy with strontium ranelate (SR) in women with postmenopausal osteoporosis (OP).Subjects and methods. The investigation enrolled 34 postmenopausal women (mean age 65±8 years), who was diagnosed...

Full description

Bibliographic Details
Main Authors: M. Yu. Krylov, O. A. Nikitinskaya, E. Yu. Samarkina, N. V. Toroptsova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2017-07-01
Series:Научно-практическая ревматология
Subjects:
strontium ranelate
osteoporosis
postmenopause
vdr and mcp-1 gene polymorphisms
bone mineral density
Online Access:https://rsp.mediar-press.net/rsp/article/view/2379

Internet

https://rsp.mediar-press.net/rsp/article/view/2379

Similar Items